Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype
Theodore S. Hong; Jennifer Y. Wo; Darrell R. Borger; Beow Y. Yeap; Erin I. McDonnell; Henning Willers; Lawrence S. Blaszkowsky; Eunice L. Kwak; Jill N. Allen; Jeffrey W. Clark; Shyam Tanguturi; Lipika Goyal; Janet E. Murphy; John A. Wolfgang; Lorraine C. Drapek; Ronald S. Arellano; Harvey J. Mamon; John T. Mullen; Kenneth K. Tanabe; Cristina R. Ferrone; Andrew X. Zhu
Author Information: Department of Radiation Oncology (TSH, JYW, HW, JAW, LCD), Department of Pathology (DRB), Division of Biostatistics, Department of Medicine (BYY, EIM), Division of Medical Oncology (LSB, ELK, JNA, JWC, LG, JEM, AXZ), Department of Medicine, Department of Radiology (RSA), and Department of Surgery (JTM, KKT, CRF), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA (ST); Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (HJM)
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.